Study of Combined Therapy of Aspirin and "IVIG-SN" in Kawasaki Disease

NCT01524939 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
45
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Green Cross Corporation